Close Menu

NEW YORK (GenomeWeb News) - Sapio Sciences said today that molecular diagnostics developer Biodesix has purchased its Exemplar laboratory information management system.

Biodesix is developing mass spectrometry-based molecular diagnostics to help physicians diagnose, treat, and monitor disease.

Sapio said that the company was looking for a LIMS that could track samples, support biobanking, and integrate with its mass spectrometry instruments.

Financial terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.

Jun
17
Sponsored by
Illumina

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.